(Q39794430)

14 September 2017

title

Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model (English)

1 reference

14 September 2017

1 reference

Peter Jantscheff

1

1 reference

14 September 2017

Vittorio Ziroli

2

1 reference

14 September 2017

Norbert Esser

3

1 reference

14 September 2017

Ralph Graeser

4

1 reference

14 September 2017

Jessica Kluth

5

1 reference

14 September 2017

Alena Sukolinskaya

6

1 reference

14 September 2017

Lenka A Taylor

7

1 reference

14 September 2017

Clemens Unger

8

1 reference

14 September 2017

Ulrich Massing

9

1 reference

14 September 2017

publication date

26 September 2009

1 reference

Clinical & Experimental Metastasis

14 September 2017

published in

1 reference

14 September 2017

volume

26

1 reference

14 September 2017

issue

8

1 reference

14 September 2017

page(s)

981-992

1 reference

https://scigraph.springernature.com/pub.10.1007/s10585-009-9288-1

14 September 2017

exact match

0 references

cites work

An in vivo mouse model for human prostate cancer metastasis.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10585-009-9288-1

The role of the organ microenvironment in the biology and therapy of cancer metastasis

21 January 2018

1 reference

12 December 2020

The study of gemcitabine in combination with other chemotherapeutic agents as an effective treatment for prostate cancer

1 reference

12 December 2020

Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines

1 reference

12 December 2020

Antimetastatic effects of liposomal gemcitabine and empty liposomes in an orthotopic mouse model of pancreatic cancer

1 reference

12 December 2020

Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels

1 reference

12 December 2020

The tumor microenvironment: key to early detection

1 reference

12 December 2020

Mechanisms of bone metastasis in prostate cancer: clinical implications

1 reference

12 December 2020

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters

1 reference

12 December 2020

A new liposomal formulation of Gemcitabine is active in an orthotopic mouse model of pancreatic cancer accessible to bioluminescence imaging.

1 reference

12 December 2020

Therapy of multidrug resistant human prostate tumors in the prostate of nude mice by simultaneous targeting of the epidermal growth factor receptor and vascular endothelial growth factor receptor on tumor-associated endothelial cells

1 reference

12 December 2020

Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis

1 reference

12 December 2020

Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.

1 reference

12 December 2020

Role of neovasculature and vascular permeability on the tumor retention of photodynamic agents

1 reference

12 December 2020

Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models

1 reference

12 December 2020

Cancer therapy with liposomal formulations of anticancer drugs.

1 reference

12 December 2020

Cancer statistics, 2002

1 reference

12 December 2020

Inhibitory effects of the nucleoside analogue gemcitabine on prostatic carcinoma cells

1 reference

12 December 2020

Cellular bases of the antitumor activity of the novel taxane IDN 5109 (BAY59-8862) on hormone-refractory prostate cancer

1 reference

12 December 2020

Future directions for gemcitabine in the treatment of genitourinary cancer

1 reference

12 December 2020

Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells

1 reference

12 December 2020

Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen).

1 reference

12 December 2020

Orthotopic implantation of human prostate cancer cell lines: a clinically relevant animal model for metastatic prostate cancer

1 reference

12 December 2020

Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness

1 reference

12 December 2020

Actinomycin D and gemcitabine synergistically sensitize androgen-independent prostate cancer cells to Apo2L/TRAIL-mediated apoptosis

1 reference

12 December 2020

Apoptosis resistance increases with metastatic potential in cells of the human LNCaP prostate carcinoma line

1 reference

12 December 2020

Expression of CEACAM6 in Resectable Colorectal Cancer: A Factor of Independent Prognostic Significance

1 reference

12 December 2020

Chemotherapeutic gemcitabine doublets in pancreatic carcinoma

1 reference

12 December 2020

Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI.

1 reference

12 December 2020

Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate

1 reference

12 December 2020

UKCCCR guidelines for the welfare of animals in experimental neoplasia

1 reference

12 December 2020

A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases

1 reference

12 December 2020

Murine models to evaluate novel and conventional therapeutic strategies for cancer

1 reference

12 December 2020

Pros and cons of the liposome platform in cancer drug targeting

1 reference

12 December 2020

Corticosteroid-induced chemotherapy resistance in urological cancers

1 reference

12 December 2020

Elevated levels of prostate-specific antigen (PSA) in prostate cancer cells expressing mutant p53 is associated with tumor metastasis

1 reference

12 December 2020

Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model

1 reference

12 December 2020

Rapid detection of candidate metastatic foci in the orthotopic inoculation model of androgen-sensitive prostate cancer cells introduced with green fluorescent protein

1 reference

12 December 2020

Pathogenesis of Ascites in Mice With Peritoneal Carcinomatosis 2

1 reference

12 December 2020

Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9

1 reference

12 December 2020

Metastatic model for human prostate cancer using orthotopic implantation in nude mice

1 reference

12 December 2020

An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line.

1 reference

12 December 2020

Synthesis and biological evaluation of an albumin-binding prodrug of doxorubicin that is cleaved by prostate-specific antigen (PSA) in a PSA-positive orthotopic prostate carcinoma model (LNCaP).

1 reference

12 December 2020

Establishment of two human prostate cancer cell lines derived from a single bone metastasis

1 reference

12 December 2020

Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer

1 reference

12 December 2020

Viable circulating metastatic cells produced in orthotopic but not ectopic prostate cancer models.

1 reference

12 December 2020

Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice

1 reference

12 December 2020

The histone deacetylase inhibitors depsipeptide and MS-275, enhance TRAIL gene therapy of LNCaP prostate cancer cells without adverse effects in normal prostate epithelial cells.

1 reference

12 December 2020

Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines

1 reference

12 December 2020

Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (review).

1 reference

12 December 2020

Imaging of bioluminescent LNCaP-luc-M6 tumors: a new animal model for the study of metastatic human prostate cancer

1 reference

12 December 2020

Liposomal gemcitabine (GemLip)-efficient drug against hormone-refractory Du145 and PC-3 prostate cancer xenografts.

1 reference

12 December 2020

Phase II study of capecitabine combined with gemcitabine in the treatment of androgen-independent prostate cancer previously treated with taxanes

1 reference

12 December 2020

Permanent phenotypic and genotypic changes of prostate cancer cells cultured in a three-dimensional rotating-wall vessel

1 reference

12 December 2020

Prostate stem cell antigen is overexpressed in prostate cancer metastases

1 reference

12 December 2020

Unusual behaviour of the LNCaP prostate tumour xenografted in nude mice.

1 reference

12 December 2020

Chemotherapy in hormone-refractory prostate cancer

1 reference

12 December 2020

Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.

1 reference

12 December 2020

Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma.

1 reference

12 December 2020

Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer

1 reference

12 December 2020

Malignant transformation of human prostatic epithelium is associated with the loss of androgen receptor immunoreactivity in the surrounding stroma.

1 reference

12 December 2020

Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor system

1 reference

12 December 2020

Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectom

1 reference

12 December 2020

Cancer statistics, 2001

1 reference

12 December 2020

10.1007/S10585-009-9288-1

Identifiers

DOI

1 reference

14 September 2017

1 reference